01 1Aurobindo Pharma Limited
02 1Chongqing Biocare Pharmaceutical Ltd.
03 1Chongqing Bioland Pharmaceutical Ltd.
04 1MYLAN LABORATORIES LIMITED
05 1Pharmacia and Upjohn Company LLC
06 2Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.
07 1Zhejiang Tiantai Pharmaceutical Co., Ltd.
01 3CLINDAMYCIN PALMITATE HYDROCHLORIDE
02 1CLindamycin Palmitate
03 2Clindamycin Palmitate
04 2Clindamycin Palmitate Hydrochloride
01 3China
02 1India
03 2U.S.A
04 2Blank
CLINDAMYCIN PALMITATE HYDROCHLORIDE
NDC Package Code : 65862-545
Start Marketing Date : 2023-11-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0009-0063
Start Marketing Date : 2014-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
CLINDAMYCIN PALMITATE HYDROCHLORIDE
NDC Package Code : 65015-759
Start Marketing Date : 2015-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
CLINDAMYCIN PALMITATE HYDROCHLORIDE
NDC Package Code : 67321-304
Start Marketing Date : 2020-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
CLINDAMYCIN PALMITATE HYDROCHLORIDE
NDC Package Code : 67321-303
Start Marketing Date : 2015-02-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
CLINDAMYCIN PALMITATE HYDROCHLORIDE
NDC Package Code : 39635-0004
Start Marketing Date : 2022-05-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 33656-0004
Start Marketing Date : 2010-11-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 79290-0002
Start Marketing Date : 2024-04-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Clindamycin Palmitate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clindamycin Palmitate, including repackagers and relabelers. The FDA regulates Clindamycin Palmitate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clindamycin Palmitate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clindamycin Palmitate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clindamycin Palmitate supplier is an individual or a company that provides Clindamycin Palmitate active pharmaceutical ingredient (API) or Clindamycin Palmitate finished formulations upon request. The Clindamycin Palmitate suppliers may include Clindamycin Palmitate API manufacturers, exporters, distributors and traders.
click here to find a list of Clindamycin Palmitate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clindamycin Palmitate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clindamycin Palmitate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clindamycin Palmitate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clindamycin Palmitate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clindamycin Palmitate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clindamycin Palmitate suppliers with NDC on PharmaCompass.
We have 5 companies offering Clindamycin Palmitate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
